PubMed · 2003 · 388 citations · 16 references
MedicineOncologyPharmacologyCancer PharmacologyChemotherapyMolecular OncologyCellular Drug EffluxChemotherapy ResistanceDrug ResistanceEfflux-mediated ResistancePharmacodynamics Of Anticancer AgentsTherapeutic ResistanceAnticancer Drug ResistanceCell Line Sensitivity ProfilingCellular Drug AccumulationDrug Efflux MechanismsDrug Efflux PumpsTherapeutic Drug ResistanceTherapeutic Resistance MechanismsVesicular Drug Efflux
Anticancer drug resistance results from selective pressure of chemotherapy, together with mutations or epigenetic changes that make cells refractory to treatment. In cancer cells, we report that gene expression associated with vesicle shedding correlates with chemosensitivity profiles. Experiments with doxorubicin and other small molecules confirm drug accumulation and expulsion in shed vesicles. Relative differences in the rate of vesicle shedding correspond with doxorubicin resistance across various cell lines. Moreover, accumulation of drug in membrane domains in which vesicles originate accounts for drug expulsion in shed vesicles. These observations implicate vesicle shedding as a drug efflux mechanism potentially involved in drug resistance.
16
Tumor-derived exosomes are a source of shared tumor rejection antigens for CTL cross-priming
Joseph Wolfers, Anne Lozier, Graça Raposo et al. · Nature Medicine · 2001 · 1.6K citations
Life Sciences, Immunology, Oncology +16
A gene expression database for the molecular pharmacology of cancer
Uwe Scherf, Douglas T. Ross, Mark Waltham et al. · Nature Genetics · 2000 · 1.5K citations
Malignant effusions and immunogenic tumour-derived exosomes
Fabrice André, Noël E.C. Schartz, Mojgan Movassagh et al. · The Lancet · 2002 · 940 citations
Life Sciences, Immunology, Oncology +14
Chemosensitivity prediction by transcriptional profiling
Jane Staunton, Donna K. Slonim, Hilary A. Coller et al. · Proceedings of the National Academy of Sciences · 2001 · 688 citations
Medicine, Cancer Biology, Oncology +13